We congratulate Laboratorio BETA for the declaration of #BIOEQUIVALENCE of the product DROPICINE®/RISPERIDONE, 1mg coated tablets.
The National Administration of Drugs, Food and Medical Technology has renewed the Authorization of FP Clinical Pharma S.R.L. to carry out PHASE IV CLINICAL PHARMACOLOGY STUDIES OF BIOEQUIVALENCE IN ADULT POPULATION.
We are ready to face your next Bioequivalence project!!!!